|
 |
Patricia Smith is a Director of Paratek. Dr. Smith is a qualified physician with 20 years of healthcare experience, ten of which
were with Zeneca Group plc (Zeneca). During her tenure with Zeneca, Dr. Smith held a number of positions in international clinical
development as well as national/international marketing. She was involved in product launches for a variety of therapeutic indications
including anti-infectives, cardiovascular and oncology, among others. As Zeneca’s UK marketing director, Dr. Smiths responsibilities
also included business development and planning within the international commerce group. A member of the Royal College of Physicians
since 1984, Dr. Smith received her medical training at the Nottingham University School of Medicine. In addition to Paratek, Dr.
Smith is also a director for XTL Biopharmaceuticals Ltd, a biopharmaceutical development company listed on the LSE. She is CEO of
Slendertone, a division of BioMedical Research Ltd and a director of BioMedical Research Ltd.
|
